a PDF of this article

Toll Free: 800-826-2926
Phone: 410-715-1700
Fax: 410-715-4511
Website: www.acell.com
FOR IMMEDIATE RELEASE
Contact:
Jon Werner
Director of Marketing
410-953-8534
ACell, Inc. Names Elizabeth Smith Senior Director, Clinical Research
Columbia, MD - (May 18, 2015) – ACell, Inc. today announced the selection of Elizabeth
Smith as Senior Director, Clinical Research. In this role, Smith will lead all ACell clinical
research initiatives and offer strategic direction for the company’s research activities.
“Elizabeth has a proven track record of effectively leading clinical teams,” said James A.
D’Orta, MD, Chief Executive Officer. “As ACell continues to grow and help more patients
in expanding therapeutic areas, our clinical research program will be an essential driver
for regulatory approvals, secure reimbursement, and post-market adoption of our
products.”
Elizabeth Smith has more than 20 years of experience in pre-clinical testing, preapproval regulated trials, post-launch clinical evaluations, and compliant marketing.
She previously served as Senior Director, Clinical Research at AgNovos Healthcare, a
start-up orthopedic company. She has held clinical management positions at a range of
medical device companies including K2M, Zimmer, Inc., St. Jude Medical, and American
Medical Systems.
“It is pivotal time for ACell, and the addition of strong talent like Elizabeth elevates our
ability to execute world-class clinical programs.” said Thomas Gilbert, Ph.D., Chief
Science Officer. “ACell has an increasing number of research projects in progress to
support our corporate growth strategies, and I am confident that Elizabeth will
effectively oversee these efforts.”
About ACell, Inc.
ACell, Inc. is a leading regenerative medicine company focused on the development,
manufacturing and commercialization of unique proprietary extracellular matrix (ECM)
products to facilitate the repair and remodeling of damaged tissues. ACell is committed
to becoming and remaining an innovative leader in regenerative medical technology,
offering superior healing options for doctors and patients. ACell is a privately held
company and operates manufacturing facilities in Columbia, MD and Lafayette, IN. For
more information, call 800-826-2926 or visit www.acell.com.
6640 Eli Whitney Drive, Columbia, MD 21046
PR-0033.0 5/2015
About MatriStem®
MatriStem products contain the epithelial basement membrane from porcine urinary
bladder, and are based on the proprietary ECM composition generally referred to in
scientific literature as urinary bladder matrix, or UBM. UBM is a segment of tissue
layers that facilitates a constructive tissue remodeling response by the patient’s body.
Different MatriStem products are indicated for use in general surgery, gynecological
surgery, and in the management of a wide range of wounds, respectively. Refer to the
IFU supplied with each product for indications, contraindications and precautions. All
MatriStem products are made in the USA.
###
PR-0033.0 5/2015